Skip to content

Assessment of Sama Nirama differntiation in patients with Rheumatoid Arthritis

The development and validation of a diagnostic tool for s ?ma nir ?ma differentiation in patients with Rheumatoid arthritis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/067095
Enrollment
30
Registered
2024-05-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M060- Rheumatoid arthritis without rheumatoid factor

Interventions

None listed

Sponsors

nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients already diagnosed as Rheumatoid Arthritis as Per 1987 Revised ACR Classification Criteria · Subjects between age group 16 to 60 yrs. · Patients of either sex irrespective of socioeconomic status.. · Patients fulfilling diagnostic criteria.

Exclusion criteria

Exclusion criteria: History of inflammatory joint disease other than RA which might interfere the Study e.g.; Systemic lupus erythematous, ankylosing spondylitis, osteoarthritis. · Subject with other major systemic illness that may interfere with the study. · Patients who were under steroid therapy. · Patients with tumors, metabolic diseases of bone. · Heart diseases or severe hypertension, any endocrine diseases Such as hyperthyroidism, and severe infection

Design outcomes

Primary

MeasureTime frame
To develop a tool for assessing S ?ma and Nir ?ma avastha in patients with confirmed diagnosis of rheumatoid arthritis. To assess the S ?ma Nir ?ma avastha in patients using the developed and validated tool.Timepoint: Team meeting with experts 24 weeks Questionnaire preparation 24 weeks Using delphi method analysing the findings 12 weeks Tool development and validation 9 months

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDurgalakshmiS

Amrita School of Ayurveda,, Amrita Vishwa Vidyapeetam,

dr.durgalakshmis@ay.amrita.edu9495701156

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026